Oesophageal Cancer Trial, Recruiting NCT02947971 Sponsor: Massachusetts General Hospital Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT02947971
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older who have previously been diagnosed with gastroesophageal reflux disease (a condition where stomach acid regularly flows back into the food pipe), also known as GERD
  • People aged 14 or older who have previously been diagnosed with eosinophilic esophagitis (a condition affecting the food pipe), also known as EoE
  • People who have previously been diagnosed with Barrett's esophagus (a condition affecting the lining of the food pipe), also known as BE
  • Healthy volunteers aged 18 to 84 years old with no such diagnoses
  • People who are able to understand and agree to the terms of participating in the trial
  • People who have not eaten solid food for at least 4 hours before the procedure, and have only had clear liquids in the 2 hours before the procedure

Who may not be able to join:

  • People aged 85 or older
  • People who have difficulty swallowing pills or capsules
  • People who have a strong gag reflex
  • People who have a hole or an abnormal connection in their food pipe, or a narrowing in the food pipe that is smaller than the size of the capsule used in the trial
  • People who are pregnant (women of childbearing age may be asked whether they are pregnant, and if unsure, may be asked to take a pregnancy test before joining)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Guillermo Tearney, MD, PhD, Massachusetts General Hospital

Phone: 617-726-5317

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 April 2016
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Assessment of quality and performance of Compact Imaging System (CIS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov